This week, Representative Caroline Maloney with the support of leaders of the Pro-Choice Caucus Reps. Barbara Lee, Diane Degette, and Ayanna Pressley introduced a resolution on medication abortion in the House of Representatives.
President and CEO Dr. Jamila Perritt issued the following response:
“I applaud Rep. Maloney and Pro-Choice Caucus leadership for introducing this important resolution making clear that policies governing access to medication abortion care should be grounded in science and medicine and be available to everyone who needs it. As an abortion provider, I know that medication abortion care is safe and effective. It deserves to be recognized as such by our political leadership.
I know that medication abortion care is safe and effective. It deserves to be recognized as such by our political leadership.
“Mifepristone, one of the two medications used in medication abortion care, faces onerous restrictions by the FDA that are not based in medical evidence. These restrictions work to push abortion care out of reach for countless people. Everyone should be able to access this essential health care in the way that meets their individual needs, including via telehealth care. Political barriers ignoring medicine and science push care out of reach for those who already face the most barriers to care including patients working to make ends meet, communities of color, young people, and those living in rural areas. PRH looks forward to continuing working with Members of Congress to pass this resolution acknowledging the importance of access to medication abortion care.”
